Meet us at booth 3253
BIO International Convention
June 22–25, 2026 · San Diego, USA
Where
Booth 3253
San Diego Convention Center, USA
When
22–25 June 2026
The world's largest biotech gathering
Who you'll meet
Our senior BD team
Commercial leadership & CDMO experts
Why meet at BIO
Bring us the molecule that keeps you up at night.
BIO is where the biotech world comes together — and where the most complex development conversations start. Ardena is an integrated CDMO and bioanalytical CRO built for the molecules that don’t follow the rules.
Whether you’re advancing a complex formulation, a nanomedicine, an HPAPI, or a sterile injectable, book time with our team to talk through your program one-to-one — before your calendar fills up.
What we can talk through
From molecule to market, under one roof.
Drug Product
Complex formulation
Bioavailability enhancement, oral solids, sterile injectables, and clinical trial supply.
Nanomedicine
Where few CDMOs dare to go
Lipid-based, polymeric and metal nanoparticles, plus ADC and XDC programs.
Drug Substance
The molecules that don't follow the rules.
PROTACs, glues & conjugates, solid state research, and high-potent API (HPAPI).
Bioanalysis
Data that moves your program forward.
Small & large molecule biomarkers, immunogenicity, flow cytometry, and qPCR.
Talk to the people who make the decisions.
Chief Commercial Officer (CCO)
Henny Zijlstra joined Ardena as Chief Commercial Officer in May 2026. She is an accomplished commercial leader in the pharmaceutical and CDMO industry, with a career built on driving growth through strategic business development, brand positioning, and customer engagement.
Global Vice President of CDMO Sales
Elena Bilello is Global Vice President of CDMO Sales at Ardena. She leads global commercial strategy and business development initiatives supporting Ardena’s integrated CDMO services. With more than 25 years of experience in sales and business development, Elena has built a strong track record in driving commercial growth, leading high-performing teams, and fostering long-term client partnerships across the pharmaceutical industry. Prior to joining Ardena, she held multiple roles at Catalent, where she led the East Coast North American Business Development team. Elena is recognized for her leadership approach, commercial expertise, and ability to support strategic partnerships across global pharmaceutical development programs.
Director of Business Development
Amber Basinger is Director of Business Development at Ardena, focused on building strategic partnerships and supporting biotech and pharmaceutical companies across the Southern United States through Ardena’s integrated CDMO services. She brings more than 11 years of experience in business development within the life sciences industry. Throughout her career, Amber has built strong relationships with emerging and established pharmaceutical organizations by supporting complex drug development and manufacturing programs. At Ardena, she works closely with clients to align development and manufacturing strategies with evolving program needs, supporting projects from early development through commercialization. Prior to joining Ardena, Amber served as an Account Executive on Catalent’s Early Phase Small Molecule team, supporting clients across early-stage drug development initiatives.
Director of Business Development
James Ngai is Director of Business Development at Ardena. He brings more than 18 years of experience across the biotech and pharmaceutical industries, combining scientific expertise with commercial leadership in support of drug development programs. With a background in analytical chemistry, James has built extensive experience in commercial growth and strategic client partnerships. Based in the San Francisco Bay Area and supporting the Pacific Northwest region, he works closely with clients to navigate CMC development and support the advancement of therapeutic programs. James is recognized for his ability to bridge scientific understanding with strategic business opportunities across pharmaceutical development and manufacturing programs.
RESERVE YOUR SLOT
Book a meeting at BIO 2026.
BIO is where the biotech world comes together — and where the most complex development conversations start. Ardena is an integrated CDMO and bioanalytical CRO built for the molecules that don’t follow the rules.
Whether you’re advancing a complex formulation, a nanomedicine, an HPAPI, or a sterile injectable, book time with our team to talk through your program one-to-one — before your calendar fills up.
